1622075-09-5

1622075-09-5 structure
1622075-09-5 structure
  • Name: Clivatuzumab
  • Chemical Name: Research Grade Clivatuzumab (DHD14205)
  • CAS Number: 1622075-09-5
  • Molecular Formula:
  • Molecular Weight:
  • Catalog: Research Areas Cancer
  • Create Date: 2023-02-12 16:50:22
  • Modify Date: 2024-04-07 09:42:28
  • Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers[1].

Name Research Grade Clivatuzumab (DHD14205)
Description Clivatuzumab is a humanized anti-mucin monoclonal antibody targeting an epitope in the MUC1 antigen expressed in most pancreatic cancers[1].
Related Catalog
In Vitro Clivatuzumab 对胰腺导管腺癌 (PDAC) 表现出高特异性,对正常和良性非肿瘤性胰腺组织几乎没有反应性,尽管它对某些其他器官(如胃、结肠、肺)的腺癌表现出有限的反应性(约占所有样本的 10%)[1]。
References

[1]. Gold DV, et al. Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin. Mol Cancer. 2013 Nov 20;12(1):143.  

No Any Chemical & Physical Properties